Dana Investment Advisors, Inc. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
Dana Investment Advisors, Inc. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$1,707,000
-20.1%
17,903
-6.3%
0.09%
-19.8%
Q2 2020$2,137,000
+42.7%
19,107
-7.3%
0.12%
+27.5%
Q1 2020$1,498,000
-13.4%
20,605
+24.3%
0.09%
+9.6%
Q4 2019$1,729,000
-3.1%
16,575
-7.5%
0.08%
-7.8%
Q3 2019$1,784,000
-13.6%
17,925
-0.9%
0.09%
-11.8%
Q2 2019$2,065,000
+0.5%
18,092
+10.7%
0.10%
+5.2%
Q1 2019$2,055,000
+21.9%
16,348
+31.6%
0.10%
+12.8%
Q4 2018$1,686,000
-45.4%
12,427
+10.5%
0.09%
-31.7%
Q3 2018$3,087,000
+12.8%
11,247
-14.8%
0.13%
+5.0%
Q2 2018$2,736,000
-1.2%
13,206
-21.2%
0.12%
-4.0%
Q1 2018$2,769,000
+10.7%
16,768
-8.2%
0.12%
+14.7%
Q4 2017$2,502,000
-2.6%
18,275
-3.2%
0.11%
-7.6%
Q3 2017$2,570,000
+10.9%
18,878
-1.1%
0.12%
+8.3%
Q2 2017$2,318,000
+17.5%
19,091
+2.4%
0.11%
+18.5%
Q1 2017$1,973,000
+6.1%
18,643
+1.9%
0.09%
+4.5%
Q4 2016$1,859,000
+2.9%
18,298
+3.4%
0.09%
+1.1%
Q3 2016$1,807,000
-12.5%
17,703
+2.2%
0.09%
-5.4%
Q2 2016$2,066,000
+26.4%
17,320
+13.5%
0.09%
+24.3%
Q1 2016$1,635,000
-5.0%
15,264
+786.9%
0.07%
-11.9%
Q4 2015$1,721,000
+17.2%
1,721
-90.0%
0.08%
+21.7%
Q3 2015$1,468,000
-30.0%
17,142
-17.6%
0.07%
-29.6%
Q2 2015$2,098,000
+54.0%
20,793
+17.7%
0.10%
+48.5%
Q1 2015$1,362,000
+46.6%
17,668
+1.2%
0.07%
+73.7%
Q4 2014$929,000
+18.8%
17,456
+4.9%
0.04%
-15.6%
Q3 2014$782,000
-7.7%
16,643
+22.5%
0.04%
-10.0%
Q2 2014$847,000
-6.5%
13,590
+0.9%
0.05%
-12.3%
Q1 2014$906,00013,4640.06%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders